Table 5. Demographic, clinical and neurophysiological parameters of patients with narcolepsy type 1 (NT1) and control subjects.
NT1 (n = 22) |
Controls (n = 22) |
|||
---|---|---|---|---|
n | % | n | % | |
Men | 14 | 63.6% | 6 | 27.3% |
Women | 8 | 36.4% | 16 | 72.7% |
Age at time of sampling, in years(1) | 24.4 [7.1–62.6] | 40.9 [3.3–67.4] | ||
BMI, in kg/m2 (1) | 23.3 [15.0–31.6] | 23.7 [16.6–31.0] | ||
Age at onset, in years(1) | 14.0 [5.0–48.0] | |||
Score at the Epworth Scale(1) | 18 [11–24] | |||
Cataplexy | 22 | 100.0% | ||
Hallucination(2) | 9 | 50.0% | ||
Sleep Paralysis(2) | 7 | 38.9% | ||
MSLT Latency, in minutes(1) | 4.58 [0.20–8.00] | |||
Number of SOREMPS(1) | 3 [2–5] |
(1)Continuous variables were expressed in median [minimum value-maximum value], (2)Information available only in 18 NT1 patients.